VIR BIOTECHNOLOGY, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.59 USD | -3.42% |
|
+9.67% | -4.72% |
| May. 02 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
| May. 02 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Other Biotechnology & Medical Research | -2.29% | +10.98% | -3.58% | -59.82% | - | 1.35B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- VIR Stock
- Charts Vir Biotechnology, Inc.
- Comparison Chart